Antitope, Faron Pharmaceuticals deal

Antitope will use its Composite Human Antibody technology to generate humanized mAbs against Stabilin 1 ( STAB1; CLEVER-1; FEEL-1) for Faron to treat cancer. Faron will own resulting IP. Financial ...